Inventor · disambiguated record
Joseph S. Adorante
Also filed as: ADORANTE JOSEPH S
26 granted patents·3 pending applications·345 citations·filing 1994–2014
96Inventor score
Top patents by PatentIndex Score
29 records- 0192US7767718B2Treating pain using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2006·Granted Aug 3, 2010·7 cites·50 claims
- 0290US7125908B2Treating pain using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2004·Granted Oct 24, 2006·21 cites·51 claims
- 0389US7705055B2Treating neurological disorders using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2006·Granted Apr 27, 2010·4 cites·46 claims
- 0488US7060723B2Treating neurological disorders using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2004·Granted Jun 13, 2006·18 cites·47 claims
- 0587US7763651B2Treating pain using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2006·Granted Jul 27, 2010·3 cites·50 claims
- 0685US8153645B2Treating pain using selective antagonists of persistent sodium currentEHRING GEORGE R·Filed 2006·Granted Apr 10, 2012·3 cites·36 claims
- 0784US5925342AMethod for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockersALLERGAN INC·Filed 1997·Granted Jul 20, 1999·90 cites·6 claims
- 0883US7361478B2High-throughput screen for identifying selective persistent sodium channels channel blockersALLERGAN INC·Filed 2005·Granted Apr 22, 2008·7 cites·20 claims
- 0982US6991910B2High-throughput screen for identifying channel blockers that selectively distinguish transient from persistent sodium channelsALLERGAN INC·Filed 2001·Granted Jan 31, 2006·21 cites·36 claims
- 1080US7754440B2High-throughput screen for identifying selective persistent sodium channels channel blockersALLERGAN INC·Filed 2008·Granted Jul 13, 2010·5 cites·12 claims
- 1179US8859780B2Benzimidazole derivatives as selective blockers of persistent sodium currentALLERGAN INC·Filed 2012·Granted Oct 14, 2014·7 cites·10 claims
- 1278US5922746AInhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucomaALLERGAN INC·Filed 1997·Granted Jul 13, 1999·27 cites·7 claims
- 1377US5573758AMethod for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockersALLERGAN INC·Filed 1995·Granted Nov 12, 1996·52 cites·10 claims
- 1476US6426358B1Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucomaALLERGAN SALES INC·Filed 2001·Granted Jul 30, 2002·5 cites·9 claims
- 1572US6420402B2Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucomaALLERGAN SALES INC·Filed 2001·Granted Jul 16, 2002·3 cites·9 claims
- 1672US5559151AMethod for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockersALLERGAN INC·Filed 1994·Granted Sep 24, 1996·20 cites·10 claims
- 1771US5705530AMethod for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockersALLERGAN INC·Filed 1996·Granted Jan 6, 1998·22 cites·12 claims
- 1867US7728034B2Treating neurological disorders using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2006·Granted Jun 1, 2010·0 cites·46 claims
- 1965US8124612B2Treating neurological disorders using selective antagonists of persistent sodium currentEHRING GEORGE R·Filed 2006·Granted Feb 28, 2012·0 cites·14 claims
- 2060US6479458B1Targeting the reverse mode of the Na+/Ca2+ exchanger for the treatment of optic neuropathy associated with glaucoma and ischemic optic neuropathyALLERGAN INC·Filed 2001·Granted Nov 12, 2002·1 cites·20 claims
- 2158US7723053B2High-throughput screen for identifying selective persistent sodium channels channel blockersALLERGAN INC·Filed 2008·Granted May 25, 2010·0 cites·18 claims
- 2254US6326389B1Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucomaALLERGAN SALES INC·Filed 1999·Granted Dec 4, 2001·6 cites·4 claims
- 2354US2002183368A1Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucomaFiled 2002·Application pending·0 cites
- 2453US9540332B2Benzimidazole derivatives as selective blockers of persistent sodium currentALLERGAN INC·Filed 2014·Granted Jan 10, 2017·0 cites·2 claims
- 2553US2002137777A1Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucomaFiled 2001·Application pending·0 cites
- 2651US6350780B1Methods and compositions for drug deliveryALLERGAN SALES INC·Filed 1999·Granted Feb 26, 2002·12 cites·12 claims
- 2746US5891911AMethod for reducing intraocular pressure in the mammalian eye by administration of calcium chelatorsALLERGAN INC·Filed 1995·Granted Apr 6, 1999·9 cites·6 claims
- 2839US5866605AMethod for providing a neuroprotective effect to the mammalian eye by administration of chloride channel blockersALLERGAN INC·Filed 1997·Granted Feb 2, 1999·2 cites·3 claims
- 2939US2008161402A1Targeting the Reverse Mode of the Na+/Ca2+ Exchanger For the Treatment of Neurodegenerative ConditionsALLERGAN INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →